Charles River Laboratories (United States)
Charles River Laboratories International, Inc., is an American pharmaceutical company specializing in a variety of preclinical and clinical laboratory, gene therapy and cell therapy services for the pharmaceutical, medical device and biotechnology industries. Derived from Wikipedia licensed CC-BY-SA.
Open Access statistics for Charles River Laboratories (United States), United States, covering academic research published from 2000 to 2023. Read More.
Open Access Percentage
53%
Total
Publications
2.1K
Total Open
Publications
1.1K
Total
Citations
32K
Open Access
Percentage
53%
Total
Publications
2.1K
Total Open
Publications
1.1K
Total
Citations
32K
Breakdown
Publisher Open
26%
Both
18%
Other Platform Open
9%
Closed
47%
Percentage of Open Access over time
Publisher Open
Both
Other Platform Open
Closed
Volume of Open Access over time
Open
Closed
Publisher Open
OA Journal 23%
216
Hybrid 29%
275
No Guarantees 48%
447
Other Platform Open
Domain 79%
455
Institution 26%
152
Preprint 13%
75
Public 8%
46
Other Internet 7%
42
Other Platform Locations
Name | Platform Type | Publications |
|---|---|---|
PubMed Central | Domain | 450 |
Europe PMC | Domain | 255 |
bioRxiv | Preprint | 37 |
Semantic Scholar | Public | 35 |
DOI | Other Internet | 25 |
University College London - UCL Discovery | Institution | 19 |
University of Cambridge - Apollo | Institution | 17 |
Research Square | Preprint | 16 |
Radboud University - Radboud Repository | Institution | 16 |
University of Dundee - Discovery Research Portal | Institution | 14 |